Digital diagnostics company ixlayer announced it will produce CVS Health's branded at-home sample collection kits.
Ixlayer's kits can test for Lyme disease, Vitamin D levels, thyroid function and sexually transmitted infections. Users are also provided education and information about what the results mean.
Consumers can now purchase the CVS Health-branded tests online or pick up a test in-store...
Diagnostics giant Labcorp is partnering with Getlabs to offer at-home sample collection for lab tests.
With the service, dubbed Getlabs for Labcorp, users can schedule an appointment online for an at-home blood draw. The phlebotomist can collect other samples like saliva, stool, urine and breath, and also measure vital signs. The collection will cost a convenience fee starting at $25.
Miami, Fla...
Diagnostics giant Labcorp is stepping deeper into the digital health space with the launch of Labcorp OnDemand, an online platform where users can order tests and possibly collect samples at home.
Patients choose tests through the platform and a physician can approve and review requests without a required doctor's visit. Some tests allow patients to collect samples in their homes, while others...
Indian wellness startup K&L Wellness Technology scores $4M in seed funding
K&L Wellness Technology, a health technology startup in India, has bagged Rs 30 crore ($4 million) from angel investors to launch its wellness app.
According to a news report, the company seeks to redefine wellness through science-based personalised solutions.
K&L Wellness, also known as RESET Tech, provides...
The diagnostics and drug-development behemoth Labcorp is stepping up its women’s health offerings through its recent purchase of Ovia Health.
Formerly known as Ovuline, Ovia Health is a digital health platform designed for the complete family care continuum. It lets users track their menstrual cycles while giving insights into fertility. It also monitors their baby’s development and supplies...
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process.
The platform was designed for LabCorp’s drug development and decentralized clinical trial business, Covance. It hopes to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use...
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19.
The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
Thanks to an updated emergency use authorization (EUA) from the FDA, LabCorp's COVID-19 RT-PCR test is now the first diagnostic test for COVID-19 that permits at-home sample collection.
Now, patients may use Q-tip-style nasal cotton swabs and saline included in LabCorp's designated self-collection kit – which the company is branding as the "Pixel by LabCorp COVID-19 Test." These samples are...
Yesterday, maternity-care-management platform Dorsata scored $5.2 million in Series A funding. Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital participated in this round.
WHAT THEY DO
Dorsata entered the market in late 2017, with its tool designed to help prevent variations in medical care during maternity and decrease the rate of preventable complications.
“We...
